InvestmentPitch Media Video Discusses FSD Pharma, a Life Sciences Holding Company, and the Closing of its Sale of Non-Core Assets for $16.4 million Globe Newswire - Wed May 11, 5:00AM CDT
Globe Newswire
Wed May 11, 5:00AM CDT
VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a life sciences holding company...
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets Business Wire - Tue May 10, 2:00AM CDT
Business Wire
Tue May 10, 2:00AM CDT
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce today the closing of the sale of...
FSD Pharma Announces Dismissal of Derivative Complaint Business Wire - Fri May 6, 9:41AM CDT
Business Wire
Fri May 6, 9:41AM CDT
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that the Company was successful in its...